arrow
D

Dwight H. Owen

ohio state university james comprehensive cancer center
H指数:37
被引数:5,992

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Real-World First-Line Treatment Characteristics and Physician Drivers in Advanced/Metastatic Non–Small Cell Lung Cancer, PD-L1 ≥ 50%, and without Actionable Genomic Alterations

真实世界中PD-L1≥50%且无可操作基因组改变晚期/转移性非小细胞肺癌的一线治疗特征及医师驱动因素

2026-10-030
OA
Impact of immune-related and non-immune related hospital admissions on survival of patients with non-small cell lung cancer receiving first-line immunotherapy

免疫相关和非免疫相关住院对接受一线免疫治疗的非小细胞肺癌患者生存的影响

2025-11-070
PRE
Long-term outcomes from pembrolizumab monotherapy in patients with advanced NSCLC, PD-L1 expression ≥ 50 %, and poor performance status: Transformer-based AI to characterize prognostic complexity

长期接受帕博利珠单抗单药治疗的患者中,具有晚期非小细胞肺癌、PD-L1表达≥50%且体力状况较差者的长期结局:基于Transformer的AI用于表征预后复杂性

2025-10-160
OAAI
Early Changes in Lymphocyte/Monocyte Ratio on Treatment as a Prognostic Marker to Predict Overall Survival in Patients with Advanced Cancer Treated with Immune Checkpoint Inhibitors

早期淋巴细胞/单核细胞比值的变化作为免疫检查点抑制剂治疗晚期癌症患者时预测总生存期的预后标志物

2025-10-010
PRE
Integrated molecular and clinical characterization of pulmonary large cell neuroendocrine carcinoma

肺大细胞神经内分泌癌的整合分子与临床特征分析

2025-08-190
OA
Early Acute Kidney Injury and Its Association With Survival in Patients With Metastatic Non-Small-Cell Lung Cancer Treated With Front-Line Immunotherapy-Based Therapies

早期急性肾损伤及其与接受一线免疫疗法治疗的转移性非小细胞肺癌患者生存期的关联

2025-07-280
OAAI
Brief Report: Central Nervous System Metastases After Chemoradiation Followed by Durvalumab for Unresectable Locally Advanced Non-Small Cell Lung Cancer

简报:对于不可切除的局部晚期非小细胞肺癌,在同步放化疗后接受度鲁瓦鲁单抗治疗出现中枢神经系统转移的情况。

2025-07-050
PREAI
Evaluating the effect of immune checkpoint inhibitor treatment on chronic obstructive pulmonary disease in lung cancer patients

免疫检查点抑制剂治疗慢性阻塞性肺疾病合并肺癌患者的疗效评价

2025-02-210
OAAI
A Phase 2 Trial of Primary Tumor Stereotactic Body Radiation Therapy Boost Before Concurrent Chemoradiation for Locally Advanced Non-Small Cell Lung Cancer
2024-11-012
PRE
Safety and efficacy outcomes of early cessation of anti-PD1 therapy in patients 80 years or older: A retrospective cohort study
2024-08-012
OA
Novel endoscopic scoring system for immune mediated colitis: a multicenter retrospective study of 674 patients
2024-08-011
PRE
Non-Small Cell Lung Cancer, Version 4.2024

非小细胞肺癌4.2024版

2024-05-0150
PRE